According to Merrimack Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -C$3.07 M. In 2023 the company made an earning of -C$2.96 M a decrease over its 2022 earnings that were of -C$2.95 M.The earnings displayed on this page is the company's Pretax Income.